Picture of Precigen logo

PGEN — Precigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Precigen Inc expected to post a loss of 6 cents a share - Earnings Preview

Precigen Inc PGEN.OQ PGEN.O is expected to show a rise in quarterly revenue when it reports  results on March 19 for the period ending December 31 2024

The Germantown Maryland-based  company is expected to report a 9.9% increase in revenue to $1.35 million from $1.23 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Precigen Inc is for a loss of 6 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Precigen Inc is $6.00​, above​ its last closing price of $1.80. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Sep. 30 2024-0.08-0.08-0.09Missed-12.5
Jun. 30 2024-0.10-0.10-0.10Met-3.7
Mar. 31 2024-0.09-0.09-0.10Missed-14.2​
Dec. 31 2023-0.08-0.13Missed-67.7
​​Sep. 30 2023-0.08-0.08-0.08Met-2.6
Jun. 30 2023-0.10-0.10-0.08Beat20​
Mar. 31 2023-0.10-0.09-0.10Missed-9.6
Dec. 31 2022-0.10-0.10-0.11Missed-10
This summary was machine generated March 17 at 20:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Precigen

See all news